Agilent Technologies Inc faces a challenging market with a 6-7% revenue decline in the latest quarter. Despite market headwinds, Agilent's CrossLab segment shows resilience with a 4-5% revenue ...
Agilent Technologies focuses on growing biopharma, PFAS testing, and advanced materials for semiconductors. Recent acquisitions and divestitures show mixed results, with potential for ...